American Capital Advisory, LLC Novo Nordisk A S Transaction History
American Capital Advisory, LLC
- $216 Billion
- Q3 2025
A detailed history of American Capital Advisory, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, American Capital Advisory, LLC holds 43 shares of NVO stock, worth $2,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43Holding current value
$2,126% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,704Shares Held
294MCall Options Held
13.7MPut Options Held
19.7M-
Bank Of America Corp Charlotte, NC14.7MShares$728 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$707 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$622 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$575 Million0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$544 Million0.31% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...